Pitfalls of Direct HDL-Cholesterol Measurements in Mouse Models of Hyperlipidemia and Atherosclerosis,
Joan Carles Escolà-Gil, 1, 2 Oscar Jorba, 1 Josep Julve-Gil, 1, 2 Francesc González-Sastre, 1, 3 Jordi Ordóñ ez-Llanos, 1, 3 Mice have become important models in lipoprotein and atherosclerosis research (1, 2 ) . Certain strains of mice, such as C57BL/6, develop hyperlipidemia-as a result of the accumulation in plasma of cholesterol-rich remnant particles-and aortic atherosclerosis when fed a high fat, high cholesterol diet (atherogenic diet) (1, 2 ) . Apolipoprotein E-deficient [apoE(Ϫ)] mice also develop hyperlipidemia-as a result of the accumulation of remnant lipoproteins that float mainly as VLDL and intermediate-density lipoprotein-and massive atherosclerosis even when they are fed a diet of regular chow, which is only 4% fat (1 ). These two mouse models currently are being used to study the effect of gene expression in atherosclerosis with at least two main goals: to understand the mechanisms underlying the genesis and progression of atherosclerosis, and to investigate the feasibility of different genetic and pharmacological interventions to stop or regress atherosclerosis and prevent its complications.
Previous studies have already been instrumental in defining the role of the different HDL particles with respect to atherosclerosis (3, 4 ) . Indeed, any study of this kind requires accurate and reproducible measurement of the cholesterol concentrations associated with the different lipoprotein fractions. For these purposes, fast protein liquid chromatography (FPLC) has been used to isolate HDL and to measure its cholesterol content (HDL-C) (5 ). This procedure can be performed using smaller volumes of plasma than with ultracentrifugation, which usually requires the use of plasma pooled from different mice. However, both preparative methods are labor-intensive. Because current experiments in mice require an increasingly larger number of animals, HDL has been also isolated by precipitation of apolipoprotein B (apoB)-containing lipoproteins using a variety of reagents (3 ). Recently, several new direct methods for testing HDL-C have been developed and adapted to many clinical chemistry laboratories (6 ) . These methods eliminate the need for precipitation and separation steps and use smaller volumes of plasma than the precipitation-based methods (6 ) . Therefore, they could be more suitable and practical for measurement of plasma HDL-C in mouse models of hyperlipidemia and atherosclerosis than those using precipitating reagents. The goal of this study was to compare the results of HDL-C measured after precipitation of apoB-containing lipoproteins with those obtained with direct HDL-C measurements.
We previously reported the procedures used in our laboratory to isolate HDL by FPLC (5 ). Precipitation of apoB-containing apolipoproteins was accomplished using a commercial phosphotungstic-MgCl 2 (PT) method (Boehringer Mannheim). Total cholesterol was measured by the CHOD-PAP method (Boehringer Mannheim-)adapted to a 911 automated analyzer (Boehringer Mannheim). Triglyceride determinations were performed using the GPO-PAP method (Boehringer Mannheim) and corrected for the glycerol content present in plasma (Sigma Diagnostics). The PEGME method (Boehringer Mannheim), a direct HDL-C assay in which the combination of polyethylene glycol-modified enzymes, ␣-cyclodextrin sulfate, and magnesium chloride provides selectivity for the determination of HDL-C (7 ), and an additional direct HDL-C method (PPD method; Daiichi; supplied to us as a gift from Izasa, Barcelona, Spain) (8 ) that uses a mixture of polymers and polyanions to complex and block apoBcontaining lipoproteins were also adapted to the 911 analyzer (Boehringer Mannheim). In both cases, noncomplexed HDL was measured using the CHOD-PAP method. All animal procedures were in accordance with published recommendations for the use of laboratory animals (9 ). All investigations in human patients were in accordance with the Helsinki Declaration of 1975 (as revised in 1983).
As a first step to achieve the goal of this study, we compared the cholesterol concentrations measured by the conventional CHOD-PAP method in HDL isolated by PT precipitation of apoB-containing lipoproteins or after FPLC. Table 1 shows these results obtained from plasma of C57BL/6 control mice and apoE(Ϫ) mice fed either regular chow diet or an atherogenic diet. HDL-C obtained after PT precipitation was Ϫ5.5% to ϩ11.0% with respect to the results obtained with FPLC; these values were not statistically different when analyzed with the Student t-test. Similar results have also been reported by others (10 ) , who compared mouse plasma HDL-C concentrations obtained using PT precipitation and ultracentrifugation. PT precipitation is, therefore, useful for measuring HDL-C in these mouse models of hyperlipidemia and atherosclerosis. The results for HDL-C obtained after PT precipitation and by the PEGME method were then compared. The HDL-C concentrations were very similar when plasmas from chow-fed control C57BL/6 mice were measured. The regression equation was: y ϭ 0.93x ϩ 0.14, r ϭ0.94, P Ͻ0.001. However, the similarity in HDL-C results disappeared when plasmas from control C57BL/6 mice fed an atherogenic diet and from chow-fed apoE(Ϫ) mice were compared (Fig. 1, A and B) . The differences between the mean HDL-C plasma concentrations obtained with PEGME and those obtained with the PT precipitation-based method were very important. The PEGME method gave results in control C57BL/6 mice fed an atherogenic diet that were 72% higher than those obtained after PT precipitation; this difference increased to 228% in chow-fed apoE(Ϫ) mice (in both cases, P Ͻ0.001, Student paired t-test). Interestingly, the discordance between the two methods seemed to be associated with the degree of hyperlipidemia because plasma VLDLcholesterol (VLDL-C) ϩ LDL-cholesterol was higher in chow-fed apoE(Ϫ) mice than in C57BL/6 mice fed an atherogenic diet. Because these two mouse models share the plasmatic accumulation of remnant lipoproteins, interference was investigated by adding increasing concentrations of VLDL isolated by ultracentrifugation from the plasma of C57BL/6 control mice fed an atherogenic diet or from chow-fed apoE(Ϫ) mice. VLDL did not substantially interfere with the precipitation-based method, but the PEGME HDL-C value increased as more VLDL was added, especially when it originated from apoE(Ϫ) mice (Fig. 1C) . Because the mean VLDL-C concentration in the plasma of control C57BL/6 and apoE(Ϫ) mice was 3.03 Fig. 1 . Comparison of results of PEGME direct and PT-based methods for plasma HDL-C in control C57BL/6 mice fed an atherogenic diet (A) and chow-fed apoE(Ϫ) mice (B) and effects of added VLDL on plasma HDL-C concentrations (C).
(C), effect of VLDL isolated by sequential ultracentrifugation from plasma of control C57BL/6 mice fed an atherogenic diet on the direct HDL-C (f) and PT-based (Ⅺ) methods and effects of VLDL isolated by sequential ultracentrifugation from plasma of chow-fed apoE(Ϫ) mice on the direct HDL-C (F) and PT-based (E) methods. and 4.52 mmol/L, respectively, it is very likely that intermediate-density lipoprotein and LDL, which in mice are also largely remnant-like particles containing apoB-48, also cause interference with the PEGME measurement of HDL-C.
HDL-C results obtained with the PPD method and the PT precipitation-based method were highly correlated when plasmas of chow-fed control C57BL/6 were measured (r ϭ 0.94; P Ͻ0.001). Similar to the results obtained with the PEGME, the HDL-C of chow-fed apoE(Ϫ) mice was 100% (P Ͻ0.001) higher when measured with the PPD method than after PT precipitation; in this case, VLDL also interfered when added to the plasma (data not shown). Therefore, the VLDL present in these mouse models of hyperlipidemia interfere with at least two different direct HDL-C methods. In addition, the plasma of other mouse models of hyperlipidemia and atherosclerosis, such as human apoA-II transgenic mice or mice deficient in LDL receptor, presented similar interferences (data not shown). Other methods of direct HDL-C measurements were not studied. The reasons included similarity with the ones tested previously (11 ) and the use of antibodies to human apolipoproteins that would not react with their mouse counterparts (1) (2) (3) (4) (5) . In our opinion, therefore, it is very likely that these methods would not be useful for HDL-C measurement in most mouse models of hyperlipidemia and atherosclerosis.
To see whether direct HDL-C methods could be subjected to interferences in patients with type III hyperlipidemia, we retrospectively selected 20 patients from our clinical lipid laboratory whose analyses at least once presented a ratio of VLDL-C/triglycerides Ͼ0.50 and nonsecondary hyperlipidemia. These patients were subjected to clinical re-examination and to new venipuncture. We demonstrated a genetic defect underlying the described biochemical alteration in only in four of these patients. Two of these cases presented the E2/E2 genotype, and another two presented an Arg1363 Ser mutation (12 ) . Of these four individuals, only one E2/E2 patient remained hyperlipidemic (cholesterol, 7.12 mmol/L; triglycerides, 4.93 mmol/L) and maintained a ratio of VLDL-C/triglyceride Ͼ0.65 upon re-analysis although he was receiving specific drug treatment. In this patient, the HDL-C values obtained with PT precipitation, PEGME, and PPD were 0.98, 0.99, and 1.05 mmol/L, respectively. There also were no differences in the results for HDL-C when these three different methods were used to analyze blood from the remaining three individuals with apparent genetic susceptibility to type III hyperlipidemia but who were normolipidemic at the time of the re-analysis. Thus, the sample size was too low to draw a valid conclusion and our results in humans cannot be compared with the recent findings of Lackner and Schmitz (13 ) who, using the PEGME direct HDL-C method in four E2/E2 nontreated patients severely affected by type III hyperlipidemia, reported similar data to ours in hyperlipidemic mice. However, our results in mice and theirs in patients with type III hyperlipidemia (13 ) show that the remnant lipoprotein particles of two different animal species are partially recognized by reagents that should recognize only HDL. This produces an important interference in at least some of the direct HDL-C methods used at present.
In summary, at least two direct methods of HDL-C measurement are not suitable for studies in at least several mouse models of hyperlipidemia and atherosclerosis. If not otherwise demonstrated, great caution should be exercised before applying direct HDL-C measurements to the plasma of other animal models of hyperlipidemia and atherosclerosis in which remnant particles are generated, such as the diet-induced hypercholesterolemic rabbit.
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